News
On 11 September 2026, Millennium International Management LP reported a 2.519 % stake in SEGRO plc via equity swap positions, with no change in overall holdings or plans to acquire or dispose additional shares. The firm also confirmed no agreements or understandings with any party to an offer or with any person acting in concert.
16/09/2026 | SEGRO Plc
Massachusetts Financial Services Company disclosed a 4.77 million‑share holding in SEGRO plc (SGRO.L) on 14 September 2026, representing 0.35 % of issued share capital. The disclosure, filed under Rule 8.3 of the Takeover Code, indicated no intention to alter the position, but the stake may afford the firm influence over SEGRO’s strategic direction...
16/09/2026 | SEGRO Plc
Over the last twelve months, the group generated about €293.6 million in free cash flow, and analysts expect this to move into a more stable, mature pattern rather than surging growth. The projections assume free cash flow in the coming decade remains in the hundreds of millions of euros, with only modest changes from year to year. When those futur...
16/09/2026 | Aeroports de Paris SA
Aeroports de Paris has delivered a 14.9% total return over the past 5 years, but the market is still pricing the stock at €108.90. The key issue is whether the company's current share price aligns with the intrinsic value suggested by a Discounted Cash Flow model of its future cash generation. The company's airport concession model can influence ho...
16/09/2026 | Aeroports de Paris SA
BBVA.MC currently holds a Zacks Rank of #2 (Buy) and a Value grade of A. The forward P/E is 12.05 and the PEG ratio is 0.77, while the P/B sits at 2.19, placing the market value below book value. These metrics contrast sharply with TD, which carries a Value grade of F, a forward P/E of 17.19 and a PEG of 1.20, underscoring BBVA’s relative valuation...
16/09/2026 | Banco Bilbao Vizcaya Argentaria, S.A.
BBVA’s valuation metrics, strong earnings and cash‑flow growth prospects, robust share‑price performance, strategic digital investments, and active risk‑transfer negotiations collectively paint a picture of a bank positioned for growth while managing emerging‑market exposure and regulatory headwinds.
16/09/2026 | Banco Bilbao Vizcaya Argentaria, S.A.
Capital‑market activity is evident through risk‑transfer (SRT) negotiations. BBVA is pursuing an SRT linked to €5 billion ($5.8 billion) of corporate loans and a separate deal for smaller‑firm loans. This follows broader European banking trends, with Santander targeting five SRTs for commercial real‑estate and Brazilian small‑mid‑size company finan...
16/09/2026 | Banco Bilbao Vizcaya Argentaria, S.A.
Share‑price performance has been strong, with a 90‑day return of 18.86% and a 1‑year total shareholder return of 59.71%. Analyst targets peg the stock at €22.99, while a DCF model values it at €38.62, suggesting the current €25.08 price reflects significant undervaluation. The bank’s presence in Mexico and Turkey drives loan and fee growth, but hea...
16/09/2026 | Banco Bilbao Vizcaya Argentaria, S.A.
Earnings outlooks are bolstered by a projected 20.1% EPS growth for the year, surpassing the industry average of 17.5%, and a 9.6% year‑over‑year cash‑flow growth versus the industry average of 6.2%. Over the past three to five years, annualized cash‑flow growth has averaged 22.4% against a 12.5% industry benchmark. Recent upward revisions to curre...
16/09/2026 | Banco Bilbao Vizcaya Argentaria, S.A.
Allarity has previously secured patent protection for the stenoparib DRP in the United States, with protection extending into April 2042, as well as in certain European jurisdictions and Australia. Related patent applications remain pending in additional international markets. The company's proprietary DRP technology has demonstrated the ability to...
16/09/2026 | Allarity Therapeutics, Inc.